Schleifer is the billionaire founder and CEO of biopharma company Regeneron. The company's success is due largely to Eylea, a treatment for age-related macular degeneration.
Schleifer is the billionaire founder and CEO of biopharma company Regeneron. The company's success is due largely to Eylea, a treatment for age-related macular degeneration.